The National Institutes of Health announced the start of two clinical trials for a potential coronavirus treatment called monoclonal antibodies.  Two treatments — remdesivir and dexamethasone — have been shown to help severely ill COVID-19 patients, but this would be the first potential drug to help patients early in the disease.

For more of this story, click here.